Related references
Note: Only part of the references are listed.60 Plus Years Later and We Are Still Trying to Learn How to Dose Vancomycin
Keith A. Rodvold
CLINICAL INFECTIOUS DISEASES (2020)
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2020)
Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016
Leonard R. Duncan et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity
B. R. Dalton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study
Frederico Carlos de Sousa Arnaud et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia
Barbara Ellen Jones et al.
JAMA INTERNAL MEDICINE (2020)
Relationship of vancomycin trough levels with acute kidney injury risk: an exposure-toxicity meta-analysis
Ioannis Bellos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Association Between Penicillin Allergy Documentation and Antibiotic Use
Kimberly G. Blumenthal et al.
JAMA INTERNAL MEDICINE (2020)
Renal Dosing of Antibiotics: Are We Jumping the Gun?
Ryan L. Crass et al.
CLINICAL INFECTIOUS DISEASES (2019)
Examining the Relationship Between Vancomycin Area Under the Concentration Time Curve and Serum Trough Levels in Adults With Presumed or Documented Staphylococcal Infections
Laura Clark et al.
THERAPEUTIC DRUG MONITORING (2019)
Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program
Daniel J. Diekema et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium
Wesley D. Kufel et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)
Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
A. J. Heffernan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia
Maren C. Cowley et al.
CHEST (2019)
Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis
Jacob Abraham et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics An Evaluation of 113 Veterans Affairs Medical Centers
A. Doran Bostwick et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates
Sheng-Hsuan Tseng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications
Diane M. Parente et al.
CLINICAL INFECTIOUS DISEASES (2018)
Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antinnicrobial stewardship programmes
Sean N. Avedissian et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Development of a vancomycin dosing approach for critically ill patients receiving hybrid hemodialysis using Monte Carlo simulation
Susan J. Lewis et al.
SAGE OPEN MEDICINE (2018)
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity
Natalie A. Finch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The Whole Price of Vancomycin: Toxicities, Troughs, and Time
Meghan N. Jeffres
DRUGS (2017)
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam et al.
CLINICAL INFECTIOUS DISEASES (2016)
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
James Baggs et al.
JAMA INTERNAL MEDICINE (2016)
The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
Wasan Katip et al.
INFECTION AND DRUG RESISTANCE (2016)
Individualized Vancomycin Dosing in Obese Patients: A Two-Sample Measurement Approach Improves Target Attainment
Joseph Hong et al.
PHARMACOTHERAPY (2015)
Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies
John P. Prybylski
PHARMACOTHERAPY (2015)
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies
Steven L. Barriere et al.
BMC INFECTIOUS DISEASES (2014)
An Intervention to Improve the Timing of Vancomycin Levels
Stacy E. F. Melanson et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
AUC Versus Peak-Trough Dosing of Vancomycin: Applying New Pharmacokinetic Paradigms to an Old Drug
Daniel L. Brown et al.
THERAPEUTIC DRUG MONITORING (2013)
What Proportion of Vancomycin Trough Levels Are Drawn Too Early? Frequency and Impact on Clinical Actions
Aileen P. Morrison et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2012)
Imperfect Gold Standards for Kidney Injury Biomarker Evaluation
Sushrut S. Waikar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Vancomycin: We Can't Get There from Here
Nimish Patel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Association of Interruptions With an Increased Risk and Severity of Medication Administration Errors
Johanna I. Westbrook et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines
Abdur Rahman Khan et al.
CLINICAL INFECTIOUS DISEASES (2010)
The impact of interruptions on clinical task completion
Johanna I. Westbrook et al.
QUALITY & SAFETY IN HEALTH CARE (2010)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Share Paper
